22 May 2013
Keywords: duramed, enjuvia, gets, fda, appros, pharmaceuticals, subsidiary
Article | 07 May 2007
Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals, has received two US Food and Drug Administration approvals related to its
Enjuvia ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 May 2007
21 May 2013
© 2013 thepharmaletter.com